Paper21106989
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Ju W and 12 others. Blood, 2011. Cited by 61 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. Papers, record 21106989. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21106989
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Janus Kinase 3 | Major topic |
| Leukemia-Lymphoma, Adult T-Cell | Major topic |
| Paraparesis, Tropical Spastic | Major topic |
| Pyrimidines | Major topic |
| Pyrroles | Major topic |
| T-Lymphocytes | Major topic |
| Adult | |
| Animals | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Cytokines | |
| Enzyme Activation | |
| Humans | |
| In Vitro Techniques | |
| Interleukin-15 | |
| Leukemia, Experimental | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| Mice, Transgenic | |
| Phosphorylation | |
| Piperidines | |
| STAT5 Transcription Factor | |
| Signal Transduction |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UL1 RR031990 | NCRR NIH HHS | United States | UL1RR031990 | PubMed and NIH | NIH RePORTER |
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| ZIANS002817 | NIH | NIH RePORTER | |||
| ZIANS003040 | NIH | NIH RePORTER | |||
| ZIASC004002 | NIH | NIH RePORTER | |||
| ZIBHG200319 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 21,310,928 | JAK blockade and HTLV. | https://conductscience.org/library/papers/21310928 |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,717,409 | IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11717409 | PubMed |
| 2 | 15,342,663 | Clinical trials for malignant lymphoma in Japan. | Jpn J Clin Oncol | 2004 | https://conductscience.org/library/papers/15342663 | PubMed |
| 3 | 8,070,818 | The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. | Immunol Rev | 1994 | https://conductscience.org/library/papers/8070818 | PubMed |
| 4 | 15,371,489 | The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing. | J Leukoc Biol | 2004 | https://conductscience.org/library/papers/15371489 | PubMed |
| 5 | 8,782,447 | STATs and cytokine specificity. | Nat Med | 1996 | https://conductscience.org/library/papers/8782447 | PubMed |
| 6 | 16,868,550 | The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16868550 | PubMed |
| 7 | 9,391,124 | Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9391124 | PubMed |
| 8 | 16,155,604 | Molecular mechanisms of cellular transformation by HTLV-1 Tax. | Oncogene | 2005 | https://conductscience.org/library/papers/16155604 | PubMed |
| 9 | 11,046,040 | Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells. | J Immunol | 2000 | https://conductscience.org/library/papers/11046040 | PubMed |
| 10 | 16,314,797 | Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts. | Transplantation | 2005 | https://conductscience.org/library/papers/16314797 | PubMed |
| 11 | 19,053,756 | Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550). | J Med Chem | 2008 | https://conductscience.org/library/papers/19053756 | PubMed |
| 12 | 1,751,370 | Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). | Br J Haematol | 1991 | https://conductscience.org/library/papers/1751370 | PubMed |
| 13 | 11,053,100 | Advances in interleukin 2 receptor targeted treatment. | Ann Rheum Dis | 2000 | https://conductscience.org/library/papers/11053100 | PubMed |
| 14 | 15,090,550 | Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15090550 | PubMed |
| 15 | 2,871,307 | HTLV-I associated myelopathy, a new clinical entity. | Lancet | 1986 | https://conductscience.org/library/papers/2871307 | PubMed |
| 16 | 7,604,283 | Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. | Science | 1995 | https://conductscience.org/library/papers/7604283 | PubMed |
| 17 | 18,785,636 | Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution. | Cytometry A | 2008 | https://conductscience.org/library/papers/18785636 | PubMed |
| 18 | 7,760,890 | Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7760890 | PubMed |
| 19 | 7,481,769 | Defective lymphoid development in mice lacking Jak3. | Science | 1995 | https://conductscience.org/library/papers/7481769 | PubMed |
| 20 | 11,156,399 | IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. | Cancer Res | 2000 | https://conductscience.org/library/papers/11156399 | PubMed |
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,534,713 | Targeted Interventions in HAM/TSP: Emerging Therapies and Future Directions - A Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42534713 | PubMed |
| 42,055,322 | The tumor suppressor NDRG2 recruits protein phosphatase 2A to suppress STAT5 phosphorylation in adult T-cell leukemia/lymphoma. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42055322 | PubMed |
| 37,221,459 | Immunopathogenesis of viral infections in neurological autoimmune disease. | BMC Neurol | 2023 | https://conductscience.org/library/papers/37221459 | PubMed |
| 37,205,097 | The potential of regulatory T cell-based therapies for alopecia areata. | Front Immunol | 2023 | https://conductscience.org/library/papers/37205097 | PubMed |
| 37,153,603 | The role of interleukin-15 in the development and treatment of hematological malignancies. | Front Immunol | 2023 | https://conductscience.org/library/papers/37153603 | PubMed |
| 35,406,451 | Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406451 | PubMed |
| 35,100,463 | Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis. | Cancer Sci | 2022 | https://conductscience.org/library/papers/35100463 | PubMed |
| 33,837,058 | Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease. | Neurol Neuroimmunol Neuroinflamm | 2021 | https://conductscience.org/library/papers/33837058 | PubMed |
| 33,491,334 | Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad. | Thorac Cancer | 2021 | https://conductscience.org/library/papers/33491334 | PubMed |
| 33,129,109 | Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia. | Transl Oncol | 2021 | https://conductscience.org/library/papers/33129109 | PubMed |
| 32,952,617 | Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review. | Ther Adv Musculoskelet Dis | 2020 | https://conductscience.org/library/papers/32952617 | PubMed |
| 32,707,925 | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates. | Molecules | 2020 | https://conductscience.org/library/papers/32707925 | PubMed |
| 32,508,847 | Th9 Cell Differentiation and Its Dual Effects in Tumor Development. | Front Immunol | 2020 | https://conductscience.org/library/papers/32508847 | PubMed |
| 31,821,442 | Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer. | J Exp Med | 2020 | https://conductscience.org/library/papers/31821442 | PubMed |
| 31,105,674 | Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31105674 | PubMed |
| 30,854,194 | 40 years of the human T-cell leukemia virus: past, present, and future. | F1000Res | 2019 | https://conductscience.org/library/papers/30854194 | PubMed |
| 30,353,031 | IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability. | Leukemia | 2019 | https://conductscience.org/library/papers/30353031 | PubMed |
| 29,867,836 | Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29867836 | PubMed |
| 29,682,185 | STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma. | Oncotarget | 2018 | https://conductscience.org/library/papers/29682185 | PubMed |
| 29,434,279 | Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma. | Leukemia | 2018 | https://conductscience.org/library/papers/29434279 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL15 | 3,600 | PubTator's text mining | https://conductscience.org/library/genes/3600 | NCBI Gene |
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL9 | 3,578 | PubTator's text mining | https://conductscience.org/library/genes/3578 | NCBI Gene |
| JAK3 | 3,718 | PubTator's text mining | https://conductscience.org/library/genes/3718 | NCBI Gene |
| STAT5A | 6,776 | PubTator's text mining | https://conductscience.org/library/genes/6776 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21106989
GET https://conductscience.org/api/papers/v1/21106989/references?page=2